About cancer
Currently, 1 in 2 people will develop cancer, and 1 in 3 will die from it.
Cancer development rate
Men
63%
Women
48%
Cancer death rate
Men
34%
Women
26%
(Source: Compiled from "National Cancer Center Japan Cancer Information Service, Updated August 3, 2021 (https://ganjoho.jp/reg_stat/statistics/stat/summary.html)”)
5-year relative survival rate for cancer
![](https://www.sonire-therapeutics.com/wp-content/themes/sonire_theme/img/graph-en.jpg)
One of the standards used to classify the progress of cancer is the internationally recognized standard adopted by the Union for International Cancer Control. There are 5 major stages based on how much the cancer has spread: Stage 0, Stage I, Stage II, Stage III, and Stage IV.
(Source: Compiled from "National Cancer Center Japan, Updated on March 17, 2020 (https://ganjoho.jp/reg_stat/statistics/stat/summary.html)")
Treatment effects and survival rates depend on the type of cancer. Among them, pancreatic cancer has a survival rate of less than 10%, making it one of the most intractable cancers. The pancreas is the first target of SONIRE, which is developing HIFU treatments to provide a new solution.